MedPath
HSA Approval

AXCEL BROMHEXINE TABLET 8 mg

SIN10906P

AXCEL BROMHEXINE TABLET 8 mg

AXCEL BROMHEXINE TABLET 8 mg

April 30, 1999

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R05CB02

bromhexine

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

BROMHEXINE HCl

8 mg

Bromhexine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL BROMHEXINE TABLET 8 mg - HSA Approval | MedPath